Literature DB >> 6830181

Case of downbeat nystagmus influenced by otolith stimulation.

B R Chambers, J J Ell, M A Gresty.   

Abstract

A patient with downbeat nystagmus and familial ataxia is described. The nystagmus was induced by static tilt away from normal upright posture, by linear acceleration of the head, and by convergence. It is inferred that the nystagmus was modulated by otolith-specific stimuli and not by stimulation of the canals. These findings demonstrate the role of otolith function in generation of eye movements in the vertical plane and support proposed interrelationships between otolith and vergence mechanisms. The nystagmus and associated oscillopsia were partially suppressed by treatment with clonazepam.

Entities:  

Mesh:

Year:  1983        PMID: 6830181     DOI: 10.1002/ana.410130218

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  5 in total

1.  Downbeat nystagmus: characteristics and localization of lesions.

Authors:  R D Yee
Journal:  Trans Am Ophthalmol Soc       Date:  1989

2.  Downbeat nystagmus indicates cerebellar or brain-stem lesions in vitamin B12 deficiency.

Authors:  L Mayfrank; U Thoden
Journal:  J Neurol       Date:  1986-06       Impact factor: 4.849

3.  A model-based theory on the origin of downbeat nystagmus.

Authors:  Sarah Marti; Dominik Straumann; Ulrich Büttner; Stefan Glasauer
Journal:  Exp Brain Res       Date:  2008-05-08       Impact factor: 1.972

4.  Monocular downbeat nystagmus.

Authors:  J Bogousslavsky; F Regli
Journal:  J Neurol       Date:  1985       Impact factor: 4.849

5.  Vestibular Disorders after Kidney Transplantation: Focus on the Pathophysiological Mechanisms Underlying the Vertical Nystagmus Associated with Tacrolimus-Related Hypomagnesamia.

Authors:  Pasquale Viola; Vincenzo Marcelli; Domenico Sculco; Davide Pisani; Alfredo Caglioti; Filippo Ricciardiello; Alfonso Scarpa; Alessia Astorina; Giuseppe Tortoriello; Luca Gallelli; Giovambattista De Sarro; Giuseppe Chiarella
Journal:  Int J Environ Res Public Health       Date:  2022-02-16       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.